New York, New York-- (Newsfile Corp. - January 29, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into TransMedics Group, Inc. (NASDAQ: TMDX) for potential ...

NEW YORK CITY, NY / ACCESS Newswire / January 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims ...

Scorpion Capital has assigned a target price of $0 to TransMedics stock, suggesting the firm believes the company's alleged misconduct poses an existential threat. Hagens Berman's Investigation of ...

What is this about: On January 10, 2025, Scorpion Capital issued a report about TransMedics. In this report, Scorpion Capital stated that in "20 years of shorting, TransMedics is the most extreme ...

WHAT IS THIS ABOUT: On January 10, 2025, Scorpion Capital issued a report about TransMedics. In this report, Scorpion Capital stated that in "20 years of shorting, TransMedics is the most extreme and ...

NDAQ:TMDX) The Schall Law Firm Invites Investors With Losses To Join An Inquiry Into TransMedics Group, Inc. For Securities Fraud ...

TransMedics Group, Inc. TMDX investors are continuing to encounter losses from the stock of late. Shares of the Andover, MA-based commercial-stage medical technology company providing organ transplant ...

The Federal Reserve's aggressive interest rate hikes have increased the cost of capital for businesses. For TransMedics, which relies on heavy infrastructure and research and development ...

The Federal Reserve's aggressive interest rate hikes have increased the cost of capital for businesses. For TransMedics, which relies on heavy infrastructure and research and development investments, ...

On Wednesday, Needham reiterated its Hold rating on TransMedics Group (NASDAQ:TMDX), following management's growth strategy update. The stock, which has seen a significant decline ...